ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

FIXX Homology Medicines Inc

0.9347
0.00 (0.00%)
Fuera de horario
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Homology Medicines Inc FIXX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.9347 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.9347 0.9347
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/3/202415:30GLOBEHomology Medicines Declares Distribution to Common..
11/3/202406:37EDGAR2Form 425 - Prospectuses and communications, business..
11/3/202406:32EDGAR2Form 8-K - Current report
21/2/202415:04EDGAR2Form 425 - Prospectuses and communications, business..
14/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
13/2/202409:11EDGAR2Form S-4/A - Registration of securities, business..
05/1/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:29EDGAR2Form 425 - Prospectuses and communications, business..
03/1/202415:26EDGAR2Form 8-K - Current report
03/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:08GLOBEHomology Medicines Receives NASDAQ Notification Regarding..
17/11/202315:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/11/202315:19EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202315:16EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202315:13EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202306:46EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202306:45EDGAR2Form 8-K - Current report
16/11/202306:17EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202306:16EDGAR2Form 8-K - Current report
16/11/202306:05PRNUSQ32 Bio and Homology Medicines Announce Merger Agreement
14/11/202315:33GLOBEHomology Medicines Reports Third Quarter 2023 Financial..
10/10/202316:22EDGAR2Form 8-K - Current report
08/9/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202315:05GLOBEHomology Medicines Reports Second Quarter 2023 Financial..
14/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202320:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202316:29EDGAR2Form 8-K - Current report
27/7/202315:05GLOBEHomology Medicines Announces Plan to Evaluate Strategic..
27/7/202315:01GLOBEHomology Medicines Announces Encouraging Initial Data from..
16/5/202307:00GLOBEHomology Medicines Announces First Data from IND-Enabling..

Su Consulta Reciente

Delayed Upgrade Clock